EID Parry (India) Ltd logo

EID Parry (India) Ltd

EIDPARRY NSE

Key Fundamentals

MicrocapFertilizersChemicals
Market Cap
₹13,967 Cr
Volatility
Moderate
P/E Ratio
29.87
EBITDA
₹3,799 Cr
Return on Equity
9.25%
Debt to Equity
0.4
Book Value
₹495.35
EPS
₹49.62
52W High
₹1,196.4
52W Low
₹698.2

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view EID Parry (India) Ltd insights

39 extracted metrics + investor summaries across FY15–FY26.

Log in — free

Tapetide Score

Data-driven rating, 0–100. How it works →

Technical Indicators

Key Insights

Weaknesses

4
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has a low return on equity of 9.49% over last 3 years.
  • Dividend payout has been low at 2.63% of profits over last 3 years
  • Promoter holding has decreased over last 3 years: -3.24%

Growth Rate

Revenue Growth
21.63% ↗
Net Income Growth
-22.12% ↘
Cash Flow Change
-20.39% ↘
ROE
-32.53% ↗
ROCE
-21.13% ↗
EBITDA Margin (Avg.)
2.52% ↘

AI Analysis — Bull vs Bear

Anthropic anthropic claude-opus-4.6 5d ago
AI opinion · based on fundamentals
Risk medium

EID Parry (India) Ltd, a Murugappa Group company with a market cap of ₹13,828 Cr, trades at a PE of 11.2x while holding a ~56% stake in Coromandel International (market cap ~₹61,000 Cr), implying significant holding company discount. Consolidated revenue grew 16% TTM to ~₹31,000 Cr, but profit declined 10% TTM and ROE has compressed to 8% in the last year from a 5-year average of 12%.

Bull Case 8
  • Massive holding company discount: EID Parry's 56% stake in Coromandel International is worth ~₹34,000 Cr, which alone is 2.5x EID Parry's entire market cap of ₹13,828 Cr
  • Attractive valuation at PE of 11.2x, significantly below the broader market and subsidiary Coromandel's PE of ~34.5x
  • Strong long-term profit compounding at 35% CAGR over 10 years demonstrates secular earnings growth capability
  • Consolidated revenue grew 16% TTM to ~₹30,664 Cr, showing topline momentum across sugar and subsidiary businesses
  • Healthy long-term stock price CAGR of 14% over 5 years and 12% over 10 years indicates sustained wealth creation
  • Diversified business across sugar, biofuels, nutraceuticals, and consumer products reduces single-segment dependency
  • Price-to-book of 1.56x is modest given the significant value of subsidiary holdings and operating businesses
  • 5-year compounded sales growth of 16% shows consistent revenue expansion capability across cycles
Bear Case 8
  • Compounded profit has declined 11% CAGR over 3 years and 10% TTM, indicating deteriorating earnings trajectory
  • ROE has fallen to 8% last year from a 3-year average of 9% and 5-year average of 12%, signaling weakening capital efficiency
  • Stock price down 32% in the last 1 year, reflecting significant market de-rating and negative sentiment
  • Promoter holding decreased by 3.24% over 3 years (from ~51.5% to ~47.3%), raising governance concerns
  • Extremely low dividend payout of 2.63% of profits over 3 years despite repeated profitability, with dividend yield of only 0.52%
  • Standalone sugar and biofuel operations reported PBT loss of ₹110 Cr in Q1 FY27 vs loss of ₹53 Cr year ago, showing widening core business losses
  • 3-year sales CAGR of only 3% indicates topline stagnation in the medium term despite recent TTM pickup
  • Seasonal and cyclical sugar business faces margin pressure from lower alcohol realizations and El Niño weather impacts

This is AI-generated analysis, not financial advice. Do your own due diligence.

AI News Digest

Anthropic anthropic claude-opus-4.6 19h ago
Headwinds 1
  • Q1FY27 PAT drops 42% YoY Aug 12

    Consolidated PAT fell to ₹142 crore from ₹246 crore YoY due to impairment charges and lower segment margins, despite revenue rising 3.4% to ₹9,017 crore.

Positives 1
  • Doubling jaggery capacity in Karnataka Aug 14

    EID Parry plans to double jaggery capacity via a new Karnataka plant targeting ₹100 crore turnover. Nutraceuticals aims for record revenue with 12-15% EBITDA margins, while CPG seeks breakeven in 4-5 quarters.

Neutral 2
  • Independent Director retires from board Aug 4

    Dr. Rea Godbole retired from EID Parry's board effective August 4, 2026, after completing two consecutive terms as Independent Director.

  • BRSR sustainability report published Jul 20

    EID Parry released its Business Responsibility and Sustainability Report for FY26, covering ESG initiatives, employee welfare, and environmental impact metrics.

TL;DR: EID Parry is investing in capacity expansion across jaggery and nutraceuticals, signaling medium-term growth ambitions. However, the sharp 42% PAT decline in Q1FY27 from impairment charges and margin compression is a near-term concern. Revenue growth remains modest at 3.4% YoY. The outlook hinges on whether new capacity drives margin recovery and whether the CPG segment reaches breakeven as guided.

Quarterly Results

  Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
7,026
9,059
7,770
5,557
6,747
9,330
8,720
6,811
8,720
11,624
10,312
7,882
9,018
Expenses
6,363
8,006
7,358
5,098
6,279
8,372
8,027
6,298
7,914
10,427
9,477
7,271
8,267
Operating Profit
664
1,053
412
459
468
959
694
513
805
1,198
835
611
751
OPM %
9%
12%
5%
8%
7%
10%
8%
8%
9%
10%
8%
8%
8%
Other Income
-11
151
41
123
60
69
117
459
90
151
60
-430
30
Interest
82
74
53
86
84
94
99
96
104
129
103
119
115
Depreciation
94
101
112
113
117
123
130
142
176
158
204
226
243
PBT
477
1,029
288
382
327
811
582
735
615
1,062
588
-162
423
Tax %
32%
24%
25%
23%
31%
27%
29%
27%
25%
28%
26%
77%
26%
Net Profit
325
782
217
294
226
592
416
539
464
766
437
-287
312
EPS in Rs
6.13
25.48
6.66
12.41
5.14
17.21
10.97
16.12
13.85
23.86
13.05
-18.74
7.96
Figures in ₹ Crores

Profit & Loss

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
13,952
15,358
14,391
15,373
16,556
17,129
18,556
23,521
35,244
29,413
31,609
38,534
38,836
Expenses
12,938
14,517
12,965
14,068
15,105
15,242
16,467
21,146
32,088
26,825
28,975
35,085
35,442
Operating Profit
1,014
841
1,426
1,305
1,450
1,887
2,089
2,375
3,156
2,588
2,633
3,450
3,395
OPM %
7%
5%
10%
8%
9%
11%
11%
10%
9%
9%
8%
9%
9%
Other Income
105
179
159
150
83
129
17
240
83
304
706
-129
-189
Interest
420
451
417
336
425
430
236
152
298
295
372
454
465
Depreciation
244
250
248
251
272
319
332
334
376
421
512
763
830
PBT
455
319
920
868
837
1,266
1,539
2,129
2,564
2,175
2,455
2,103
1,911
Tax %
39%
45%
23%
40%
48%
30%
35%
26%
29%
26%
28%
34%
—
Net Profit
276
175
708
517
438
889
1,000
1,574
1,828
1,618
1,773
1,380
1,227
EPS in Rs
6.64
1.96
29.61
14.45
8.67
26.43
25.26
51.12
53.37
50.68
49.41
32.02
26.13
Div. Payout %
89%
0%
14%
21%
35%
0%
0%
22%
18%
8%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
18
18
18
18
18
18
18
18
18
18
18
18
Reserves
2,209
2,370
2,733
2,952
3,110
3,502
4,565
5,308
6,067
7,040
7,918
8,748
Borrowings
4,823
5,144
3,923
4,470
5,125
4,347
1,229
1,259
1,618
1,740
2,704
3,528
Other Liabilities
5,849
6,600
6,691
7,088
7,649
7,069
7,444
9,358
11,076
12,688
13,731
16,917
Total Liabilities
12,899
14,131
13,364
14,528
15,901
14,936
13,257
15,943
18,778
21,487
24,371
29,212
Fixed Assets
3,476
3,343
3,297
3,197
3,077
3,858
3,583
3,763
3,889
4,896
6,148
8,240
CWIP
75
77
39
54
203
85
206
160
486
520
422
357
Investments
369
688
569
430
418
413
453
563
609
1,275
1,453
2,477
Other Assets
8,979
10,022
9,459
10,847
12,203
10,579
9,014
11,456
13,794
14,796
16,348
18,138
Total Assets
12,899
14,131
13,364
14,528
15,901
14,936
13,257
15,943
18,778
21,487
24,371
29,212
Figures in ₹ Crores

Cash Flow

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
222
437
1,969
259
-52
1,986
4,771
2,278
359
1,974
1,936
1,542
Investing
-307
-192
-148
13
-357
-282
-548
-1,732
487
-1,740
-2,783
-173
Financing
-142
-221
-1,842
42
34
-1,769
-3,598
-499
-184
-497
74
-551
Net Cash Flow
-227
23
-21
314
-375
-65
625
47
661
-263
-772
818
Free Cash Flow
35
233
1,839
82
-396
1,628
4,455
1,845
-370
1,051
1,323
5
CFO/OP
36
73
160
48
24
126
252
117
33
101
102
67
Figures in ₹ Crores

Ratios

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
45
49
47
43
46
45
17
9
8
23
20
22
Inventory Days
138
124
127
134
175
131
112
111
81
112
101
107
Days Payable
141
145
170
174
172
141
124
114
84
121
113
116
Cash Conversion Cycle
42
27
4
3
49
35
6
6
5
14
8
13
Working Capital Days
-1
2
15
4
17
36
45
29
27
27
14
21
ROCE %
11%
9%
16%
16%
14%
18%
21%
26%
27%
20%
17%
17%

Shareholding Pattern

As of Jun 2026
Promoters 41.28%
Public 23.97%
DIIs 16.67%
FIIs 11.21%
Others 6.88%
Total 100.01%
  Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters
44.74%
44.74%
44.68%
44.66%
44.64%
44.61%
44.55%
44.55%
44.55%
44.51%
44.51%
42.23%
42.23%
42.23%
42.22%
41.69%
41.61%
41.54%
41.49%
41.44%
41.44%
41.28%
FIIs
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
8.71%
8.85%
10.22%
10.66%
12.64%
12.17%
12.66%
12.77%
12.61%
12.21%
11.21%
DIIs
2.31%
3.82%
4.23%
3.93%
4.12%
4.18%
4.23%
4.12%
4.92%
4.76%
4.22%
4.92%
11.87%
12.45%
13.29%
13.29%
13.83%
14.46%
15.57%
16.28%
16.75%
16.67%
Government
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Public
34.12%
33.05%
33.51%
33.15%
32.75%
31.69%
29.17%
29.56%
29.47%
30.26%
31.68%
33.64%
28.85%
27.11%
26.31%
25.17%
25.15%
24.39%
23.27%
22.72%
22.81%
23.97%
Others
18.83%
18.39%
17.58%
18.26%
18.48%
19.52%
22.05%
21.78%
21.06%
20.46%
19.59%
10.49%
8.20%
7.99%
7.52%
7.20%
7.24%
6.95%
6.90%
6.94%
6.80%
6.88%
No. of Shareholders
58,101
68,369
72,531
69,729
75,303
76,121
78,194
82,503
79,937
88,142
1,07,640
1,08,246
1,07,011
1,18,928
1,26,722
1,26,023
1,25,719
1,18,705
1,19,631
1,13,020
1,12,286
1,24,851

Documents

Frequently Asked Questions about EID Parry (India) Ltd

What does EID Parry (India) Ltd do?
EID Parry is engaged in Sugar, Nutraceuticals and ethanol production. It also has a significant presence in the Farm Inputs business including Bio pesticides through its subsidiary, Coromandel International Limited. [1]
Where is EID Parry (India) Ltd (EIDPARRY) listed?
EID Parry (India) Ltd is listed on the Indian stock exchanges. It is listed on NSE: EIDPARRY and BSE: 500125. You can view its live share price, financials, and ratios on Tapetide.
Which sector does EID Parry (India) Ltd belong to?
EID Parry (India) Ltd operates in the Chemicals sector within the Fertilizers industry. Sector classification helps investors compare companies affected by similar economic conditions and regulatory changes.
What is the market capitalisation of EID Parry (India) Ltd?
EID Parry (India) Ltd has a market capitalisation of approximately ₹13967.19 Cr. Based on this, it is classified as a Mid Cap stock.
What is the PE ratio of EID Parry (India) Ltd?
The Price-to-Earnings (PE) ratio of EID Parry (India) Ltd is 29.87. The PE ratio compares a company's share price to its earnings per share and is commonly used to assess whether a stock is overvalued or undervalued relative to its peers.
What is the 52-week high and low of EID Parry (India) Ltd?
Over the past 52 weeks, EID Parry (India) Ltd has traded between a low of ₹698.2 and a high of ₹1,196.4. This range helps investors understand the stock's price volatility and recent trading levels.
Does EID Parry (India) Ltd pay dividends?
Yes, EID Parry (India) Ltd has a dividend yield of 0.51%. Dividend yield indicates the annual dividend income relative to the share price. A consistent dividend history can signal financial stability.
What is the Return on Equity (ROE) of EID Parry (India) Ltd?
EID Parry (India) Ltd has a Return on Equity (ROE) of 9.25%. ROE measures how effectively a company uses shareholders' equity to generate profits. A higher ROE generally indicates better capital efficiency.
How can I research EID Parry (India) Ltd on Tapetide?
On Tapetide, you can view EID Parry (India) Ltd's live share price, quarterly results, profit & loss statements, balance sheet, cash flow, key ratios, shareholding pattern, technical indicators, analyst ratings, and forecasts — all on a single page without needing to sign up.

Company Information

EID Parry is engaged in Sugar, Nutraceuticals and ethanol production. It also has a significant presence in the Farm Inputs business including Bio pesticides through its subsidiary, Coromandel International Limited. [1]

Website eidparry.com
CEO Mr. Muthiah Murugappan
Employees 2,384
Listed 1995-05-10
Face Value ₹ 1
Issued Size 17,78,72,717

Explore More

More in Chemicals → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List